These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 32161313)
1. Author Correction: Human neutrophils phagocytose and kill Acinetobacter baumannii and A. pittii. Lázaro-Díez M; Chapartegui-González I; Redondo-Salvo S; Leigh C; Merino D; Segundo DS; Fernández A; Navas J; Icardo JM; Acosta F; Ocampo-Sosa A; Martínez-Martínez L; Ramos-Vivas J Sci Rep; 2020 Mar; 10(1):4797. PubMed ID: 32161313 [TBL] [Abstract][Full Text] [Related]
2. Comparison between bacteremia caused by Acinetobacter pittii and Acinetobacter nosocomialis. Liu YM; Lee YT; Kuo SC; Chen TL; Liu CP; Liu CE J Microbiol Immunol Infect; 2017 Feb; 50(1):62-67. PubMed ID: 25735795 [TBL] [Abstract][Full Text] [Related]
3. First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment. Larcher R; Pantel A; Arnaud E; Sotto A; Lavigne JP BMC Infect Dis; 2017 Jul; 17(1):477. PubMed ID: 28683724 [TBL] [Abstract][Full Text] [Related]
4. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. Wisplinghoff H; Paulus T; Lugenheim M; Stefanik D; Higgins PG; Edmond MB; Wenzel RP; Seifert H J Infect; 2012 Mar; 64(3):282-90. PubMed ID: 22209744 [TBL] [Abstract][Full Text] [Related]
5. Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro. Lázaro-Díez M; Navascués-Lejarza T; Remuzgo-Martínez S; Navas J; Icardo JM; Acosta F; Martínez-Martínez L; Ramos-Vivas J Microbes Infect; 2016 Sep; 18(9):559-64. PubMed ID: 27235198 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Park YK; Jung SI; Park KH; Kim SH; Ko KS Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405 [TBL] [Abstract][Full Text] [Related]
8. Acinetobacter pittii isolated more frequently than Acinetobacter baumannii in blood cultures: the experience of a French hospital. Pailhoriès H; Tiry C; Eveillard M; Kempf M J Hosp Infect; 2018 Jul; 99(3):360-363. PubMed ID: 29577994 [TBL] [Abstract][Full Text] [Related]
9. Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore. Koh TH; Tan TT; Khoo CT; Ng SY; Tan TY; Hsu LY; Ooi EE; Van Der Reijden TJ; Dijkshoorn L Epidemiol Infect; 2012 Mar; 140(3):535-8. PubMed ID: 21733253 [TBL] [Abstract][Full Text] [Related]
10. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii. Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand. Singkham-In U; Chatsuwan T J Med Microbiol; 2018 Dec; 67(12):1667-1672. PubMed ID: 30311872 [TBL] [Abstract][Full Text] [Related]
12. Acinetobacter pittii and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China. Wang X; Chen T; Yu R; Lü X; Zong Z Diagn Microbiol Infect Dis; 2013 Jul; 76(3):392-5. PubMed ID: 23639796 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan. Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729 [TBL] [Abstract][Full Text] [Related]